HKD 0.5
(-3.85%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 979.24 Million HKD | -11.01% |
2022 | 1.1 Billion HKD | -8.87% |
2021 | 1.2 Billion HKD | 35.63% |
2020 | 890.2 Million HKD | 14.51% |
2019 | 777.4 Million HKD | 6.18% |
2018 | 732.17 Million HKD | 13.1% |
2017 | 647.34 Million HKD | 8.67% |
2016 | 595.68 Million HKD | 7.43% |
2015 | 554.47 Million HKD | 3.85% |
2014 | 533.9 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 525.17 Million HKD | 0.0% |
2023 Q1 | 239.59 Million HKD | -57.09% |
2023 Q2 | 479.19 Million HKD | 100.0% |
2023 Q3 | 250.02 Million HKD | -47.82% |
2023 Q4 | 500.04 Million HKD | 100.0% |
2023 FY | 979.24 Million HKD | -11.01% |
2022 Q1 | 271.02 Million HKD | -58.84% |
2022 FY | 1.1 Billion HKD | -8.87% |
2022 Q4 | 558.31 Million HKD | 100.0% |
2022 Q3 | 279.15 Million HKD | -48.5% |
2022 Q2 | 542.05 Million HKD | 100.0% |
2021 FY | 1.2 Billion HKD | 35.63% |
2021 Q1 | 274.44 Million HKD | -47.42% |
2021 Q4 | 658.53 Million HKD | 100.0% |
2021 Q2 | 548.88 Million HKD | 100.0% |
2021 Q3 | 329.26 Million HKD | -40.01% |
2020 Q2 | 368.2 Million HKD | 100.0% |
2020 Q4 | 521.99 Million HKD | 100.0% |
2020 FY | 890.2 Million HKD | 14.51% |
2020 Q1 | 184.1 Million HKD | -54.21% |
2020 Q3 | 260.99 Million HKD | -29.12% |
2019 Q2 | 375.34 Million HKD | 100.0% |
2019 Q1 | 187.67 Million HKD | -47.7% |
2019 FY | 777.4 Million HKD | 6.18% |
2019 Q4 | 402.06 Million HKD | 100.0% |
2019 Q3 | 201.03 Million HKD | -46.44% |
2018 FY | 732.17 Million HKD | 13.1% |
2018 Q4 | 358.84 Million HKD | 100.0% |
2018 Q3 | 179.42 Million HKD | -3.88% |
2018 Q2 | 186.66 Million HKD | 0.0% |
2018 Q1 | 186.66 Million HKD | 9.29% |
2017 Q1 | 152.87 Million HKD | 4.14% |
2017 FY | 647.34 Million HKD | 8.67% |
2017 Q4 | 170.79 Million HKD | 0.0% |
2017 Q3 | 170.79 Million HKD | 11.72% |
2017 Q2 | 152.87 Million HKD | 0.0% |
2016 FY | 595.68 Million HKD | 7.43% |
2016 Q1 | 151.03 Million HKD | 1.42% |
2016 Q2 | 151.03 Million HKD | 0.0% |
2016 Q4 | 146.8 Million HKD | 0.0% |
2016 Q3 | 146.8 Million HKD | -2.81% |
2015 Q4 | 148.92 Million HKD | 7.43% |
2015 Q3 | 138.61 Million HKD | 0.0% |
2015 Q2 | 138.61 Million HKD | 0.0% |
2015 Q1 | 138.61 Million HKD | 0.0% |
2015 FY | 554.47 Million HKD | 3.85% |
2014 FY | 533.9 Million HKD | 0.0% |
2014 Q4 | 138.61 Million HKD | 3.85% |
2014 Q3 | 133.47 Million HKD | 0.0% |
2014 Q2 | 133.47 Million HKD | 0.0% |
2014 Q1 | 133.47 Million HKD | 0.0% |
2013 Q4 | 133.47 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -191.427% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -14752.723% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -441.032% |
Prosperous Future Holdings Limited | 470.33 Million HKD | -108.202% |
Huasheng International Holding Limited | 565.9 Million HKD | -73.039% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | -265.355% |
EC Healthcare | 4.21 Billion HKD | 76.746% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 52.631% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 86.629% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -6393.203% |
Takbo Group Holdings Limited | 215.59 Million HKD | -354.212% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | -13.043% |